AG00IAS6

61-12-1 | 4-Quinolinecarboxamide, 2-butoxy-N-[2-(diethylamino)ethyl]-,monohydrochloride

AG00IAS6

SDS

COA

TIP This product is typically in stock.Please contact us for quotation.

Request For Quotation

• mg
• g
• kg
• ml
• L

无数据

• mg
• g
• kg
• ml
• L

无数据

无数据

Inquire

CAS Number	61-12-1
Catalog Number	AG00IAS6(AGN-PC-0SYY6Z)
Chemical Name	4-Quinolinecarboxamide, 2-butoxy-N-[2-(diethylamino)ethyl]-,monohydrochloride
EC Number	200-498-1
IUPAC Name	2-butoxy-N-[2-(diethylamino)ethyl]quinoline-4-carboxamide;hydrochloride
InChI	InChI=1S/C20H29N3O2.ClH/c1-4-7-14-25-19-15-17(16-10-8-9-11-18(16)22-19)20(24)21-12-13-23(5-2)6-3;/h8-11,15H,4-7,12-14H2,1-3H3,(H,21,24);1H
InChI Key	IVHBBMHQKZBJEU-UHFFFAOYSA-N
MDL Number	MFCD00012735
Molecular Formula	C20H30ClN3O2
Molecular Weight	379.9241
NSC Number	756724
SMILES	Cl.C(=O)(NCCN(CC)CC)c1c2c(nc(c1)OCCCC)cccc2
UNII	Z97702A5DG
Synonyms	Dibucaine hydrochloride, 61-12-1, Dibucaine HCl, Cinchocaine HCL, Cinchocaine hydrochloride, Dibucaine (Cinchocaine) HCl, Cincaine chloride, Dibucaine (hydrochloride), Percain, Percaine, Sovcain, Sovcainum, UNII-Z97702A5DG, Percamin S, Cincaine hydrochloride, Cinchocainium chloride, 2-Butoxy-N-(2-(diethylamino)ethyl)quinoline-4-carboxamide hydrochloride, Nupercaine hydrochloride, MLS000028429, Heavy Solution Nupercaine, Benzolin (local anesthetic), Z97702A5DG, Cinchokain hydrochlorid [Czech], AK326166, SMR000058369, EINECS 200-498-1, C 3225, 2-Butoxy-N-(2-diethylaminoethyl)-4-quinolinecarboxamide hydrochloride, 2-butoxy-N-[2-(diethylamino)ethyl]quinoline-4-carboxamide hydrochloride, CHEBI:59735, Butoxycinchoninic acid diethylethylenediamide hydrochloride, Cinchokain hydrochlorid, 4-Quinolinecarboxamide, 2-butoxy-N-(2-(diethylamino)ethyl)-, monohydrochloride, Dibucaine hydrochloride [USP:JAN], Percamin (TN), 2-butoxy-N-[2-(diethylamino)ethyl]quinoline-4-carboxamide;hydrochloride, AC1LAWAM, PubChem20328, CINCHONINAMIDE, 2-BUTOXY-N-(2-(DIETHYLAMINO)ETHYL)-, MONOHYDROCHLORIDE, dibucaine-cinchocaine-hcl, Opera_ID_1096, SCHEMBL31303, MLS001076275, C20H29N3O2.HCl, Nupercaine hydrochloride (TN), SPECTRUM1500236, CHEMBL1200612, CTK8F9136, HY-B0552A, HMS1920E14, Pharmakon1600-01500236, BCP04769, EBD27501, KS-00000F9B, CCG-40219, Dibucaine hydrochloride (JP17/USP), MFCD00012735, NSC756724, s4038, AKOS015897111, API0002315, BCP9000604, CS-2657, MCULE-2036117305, NSC-756724, NCGC00094647-01, NCGC00094647-02, NCGC00094647-03, AC-15501, AN-23641, AS-12541, SC-26885, BCP0726000008, AB0012106, AB1004834, FT-0666517, ST50319978, SW196475-3, D02220, 012D735, A833051, Dibucaine hydrochloride, analytical standard, >=99%, I08-0084, Q-100001, Cinchocaine Hydrochloride 1.0 mg/ml in Methanol (as free base), 2-butoxy-N-(2-diethylaminoethyl)quinoline-4-carboxamide hydrochloride, 2-Butoxy-N-[2-(diethylamino)-ethyl]-4-quinoline carboxamide hydrochloride, 2-butoxy-N-[2-(diethylamino)ethyl]-4-quinolinecarboxamide hydrochloride, 2-Butoxy-N-[2-(diethylamino)ethyl]-4-quinolinecarboxamide monohydrochloride, Cinchocaine hydrochloride, European Pharmacopoeia (EP) Reference Standard, Dibucaine hydrochloride, United States Pharmacopeia (USP) Reference Standard, N-[2-(diethylamino)ethyl](2-butoxy(4-quinolyl))carboxamide, chloride, 4-quinolinecarboxamide, 2-butoxy-N-[2-(diethylamino)ethyl]-, hydrochloride (1:1), 4-Quinolinecarboxamide, 2-butoxy-N-[2-(diethylamino)ethyl]-,monohydrochloride, 2- paragraph sign inverted exclamation markNo>>u-N-(2- paragraph signthornOO degrees +/-OO>>u)-4-a-sso(1/4)xo pound degrees . NIEaNI, 2-Butoxy-N-[2-(diethylamino)ethyl]-4-quinolinecarboxamide monohydrochloride; 2-Butoxy-N-(2-diethylaminoethyl)cinchoninamide hydrochloride, dibucaine, Nupercainal, Sovcaine, Cinchocaine, Nupercaine, cinchocainhydrochlorid-, Dibucaine-d9 Hydrochloride, C20H29N3O2.ClH, Dibucaine hydrochloride [JAN], C20-H29-N3-O2.Cl-H, CID521951, CS-O-04057, 2-Butoxy-N-(2-diethylaminoethyl)cinchoninamide hydrochloride, 2-N-Butoxy-N-(2-diethylaminoethyl)cinchoninamide hydrochloride, 2-Butoxy-N-(2-(diethylamino)ethyl)cinchoninamide monohydrochloride, 2-Butoxy-N-(2-diethylaminoethyl)cinchoninic acid amide hydrochloride, 4-Quinolinecarboxamide, 2-butoxy-N-[2-(diethylamino)ethyl]-, monohydrochloride, 85-79-0,

Complexity	387
Compound Is Canonicalized	Yes
Covalently-Bonded Unit Count	2
Defined Atom Stereocenter Count	0
Defined Bond Stereocenter Count	0
Exact Mass	379.203g/mol
Formal Charge	0
Heavy Atom Count	26
Hydrogen Bond Acceptor Count	4
Hydrogen Bond Donor Count	2
Isotope Atom Count	0
Molecular Weight	379.929g/mol
Monoisotopic Mass	379.203g/mol
Rotatable Bond Count	10
Topological Polar Surface Area	54.5A^2
Undefined Atom Stereocenter Count	0
Undefined Bond Stereocenter Count	0

GHS Hazard and Precautionary Statements

Symbol:
Hazard Class
Hazard statements	H302-H318
Packing Group
Precautionary statements	P264-P280i-P301+P312a-P305+P351+P338-P310a-P501a
UN Code

Certificate of Analysis

Lot Number